Vaccine Stockpiling Will Not Encourage Development, Wyeth Exec Says
Executive Summary
Vaccine manufacturers look for market growth potential when selecting projects, Wyeth Exec VP George Siber, MD, said
You may also be interested in...
FDA To Determine Flu Vaccine Suppliers For 2005-2006 Season In January
FDA will decide whether Chiron can produce flu vaccine for next season by Jan. 5, Acting Commissioner Lester Crawford, PhD, said Nov. 18
FDA To Determine Flu Vaccine Suppliers For 2005-2006 Season In January
FDA will decide whether Chiron can produce flu vaccine for next season by Jan. 5, Acting Commissioner Lester Crawford, PhD, said Nov. 18
Sanofi-Aventis Menactra Market Is $3.5 Bil. Over 10 Years, CDC Says
The potential market for Sanofi-Aventis' meningococcal conjugate vaccine Menactra is $3.5 bil. over 10 years, a Centers for Disease Control & Prevention analysis indicates